Elucid’s Dashboard Gives Real Time Patient Adherence Data During Trials
Elucid Digital Health’s Pill Connect dispensing system provides the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time. The dashboard is created by the dispensing of the pill/tablet through the intelligent Pill Connect cap, which reads a signal sent from the patients phone. The patient also has the opportunity to respond to the alert by tapping on the screen that they don’t feel well or that the pills are upsetting them.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
